Clinical trial
Intestinal Microbiota Therapy Versus Metronidazole for Primary Clostridium Difficile Infection: a Randomized Controlled Trial
NCT02301000 is registered in ClinicalTrials.gov with Oslo University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Intestinal Microbiota Therapy Versus Metronidazole for Primary Clostridium Difficile Infection: a Randomized Controlled Trial
- Lead sponsor
- Oslo University Hospital
- Phase
- Phase 2/3
- Overall status
- Terminated
- Start date
- February 22, 2015
- Completion date
- November 16, 2017
- Enrollment
- 21 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
clostridium difficile infection